|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0292 USD | -12.97% |
|
-26.08% | +12.31% |
| 05-18 | Adaptimmune Therapeutics plc Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| 11-17 | Adaptimmune Therapeutics plc Announces CEO Changes | CI |
Quotes 5-day view: Adaptimmune Therapeutics plc
Delayed Quote OTC Markets
| 2026-07-20 | 2026-07-21 | 2026-07-22 | 2026-07-23 | 2026-07-24 | |
|---|---|---|---|---|---|
| Last | US$0.0330 | US$0.0300 | US$0.0285 | US$0.0336 | US$0.0292 |
| Volume | 260,271 | 169,124 | 55,496 | 230,657 | 141,196 |
| Change | -16.46% | -9.09% | -5.00% | +17.72% | -12.97% |
| Opening | US$0.0275 | US$0.0330 | US$0.0281 | US$0.0252 | US$0.0253 |
| High | US$0.0395 | US$0.0330 | US$0.0330 | US$0.0395 | US$0.0395 |
| Low | US$0.0200 | US$0.0280 | US$0.0281 | US$0.0252 | US$0.0253 |
Performance
| 1 day | -12.97% | ||
| 1 week | -26.08% | ||
| Current month | -20.00% | ||
| 1 month | -18.89% | ||
| 3 months | +192.00% | ||
| 6 months | -16.57% | ||
| Current year | +12.31% | ||
| 1 year | -91.21% | ||
| 3 years | -96.88% | ||
| 5 years | -99.19% | ||
| 10 years | -99.61% |
Volumes
marketsDaily volume
141,196
Estimated daily volume
141,196
Avg. Volume 20 sessions
567,995
Daily volume ratio
0.25
Avg. Volume 20 sessions USD
16,585.45
Record volume 1
825,386,452
Record volume 2
556,930,770
Record volume 3
516,546,145
Capital turnover ratio
0
Float rotation
0
Basic data
Market Cap (USD)
7,739,506
Net sales (USD)
5,924,000
Number of employees
272
Sales / Employee (USD)
21,779
Free-Float
14.03 %
Free-Float capitalization (USD)
6,512,889
Average Daily Capital Traded
0.21%
Indicators
Moving average 5 days
0.0309
Moving average 20 days
0.0354
Moving average 50 days
0.0289
Moving average 100 days
0.0209
Price spread / (MMA5)
+5.82%
Price spread / (MMA20)
+21.23%
Price spread / (MMA50)
-1.03%
Price spread / (MMA100)
-28.42%
RSI 9 days
49.95
RSI 14 days
50.81
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -12.97% | -26.08% | -91.21% | -96.88% | 7.74M | |
| +0.63% | -3.06% | +16.18% | -9.78% | 66.74B | |
| +1.23% | +2.80% | +37.51% | +202.14% | 53.32B | |
| +10.08% | +51.80% | +51.80% | +51.80% | 48.12B | |
| -1.32% | -7.38% | -57.63% | -57.10% | 38.25B | |
| +0.78% | -1.84% | +52.49% | -27.01% | 29.85B | |
| +0.84% | +0.36% | +66.93% | +85.42% | 23.51B | |
| -5.17% | -12.54% | +58.98% | -56.04% | 21.45B | |
| -1.21% | +1.12% | +1.98% | +170.93% | 19.97B | |
| -0.22% | -0.95% | +61.97% | +123.78% | 16.38B | |
| Average | -0.14% | -3.50% | +19.90% | +38.73% | 31.76B | |
| Weighted average by Cap. | +1.81% | -0.11% | +27.79% | +49.98% |
Historical Quotes: Adaptimmune Therapeutics plc
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Latest transactions
e3a030cc9b04025478e032fd59.-XDtjBLXE1GU5Xqx_l2_Q4MCfema5BCdQ9l6NO-JCxg.sDa3-1qxVWjRkDXpmCvud-4wUKKo3UjKLZ5NXa7qOW_IOLL2XodiN_vSLw
| Date | Price | Volume | Total |
|---|---|---|---|
| 15:57:00 | 0.0292 | 6,000 | 140,881 |
| 15:49:38 | 0.0385 | 4,500 | 134,881 |
| 15:49:38 | 0.0385 | 2,000 | 130,381 |
| 15:46:27 | 0.0292 | 5,000 | 128,381 |
| 15:33:46 | 0.0310 | 400 | 123,381 |
| 15:33:46 | 0.0310 | 161 | 122,981 |
| 15:14:15 | 0.0291 | 250 | 122,820 |
| 15:04:54 | 0.0385 | 15,032 | 122,570 |
| 15:04:52 | 0.0385 | 4,968 | 107,538 |
| 14:30:57 | 0.0288 | 1,178 | 102,570 |
Course Extremes
| 1 week | 0.02 |  | 0.04 |
| 1 month | 0.02 | | 0.05 |
| Current year | 0 | | 0.05 |
| 1 year | 0 | | 0.28 |
| 3 years | 0 | | 2.05 |
| 5 years | 0 | | 6.86 |
| 10 years | 0 | | 14.62 |
Monthly variations
Annual variations
| 2026 | +12.31% | ||
| 2025 | -95.17% | ||
| 2024 | -32.07% | ||
| 2023 | -45.68% | ||
| 2022 | -61.07% | ||
| 2021 | -30.43% | ||
| 2020 | +349.17% | ||
| 2019 | -79.13% | ||
| 2018 | -13.92% | ||
| 2017 | +64.94% | ||
| 2016 | -66.42% | ||
| 2015 | -30.01% |
- Stock Market
- Stocks
- ADAPY Stock
- Quotes Adaptimmune Therapeutics plc
Select your edition
All financial news and data tailored to specific country editions
